PMS2 and Lynch syndrome: Moreover, as patients with Lynch syndrome harbor an elevated risk for the development of second primary malignancies after a colorectal cancer diagnosis (29), this compels the need for further clinical and laboratory-based investigations into existing colorectal cancer susceptibility genes like PMS2—specific to and representative of all population groups—in order to reduce clinical uncertainty.